🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dynamic Assessment of the Risk for Language and Reading Disorders in Monolingual and Multilingual Children

RecruitingNAAges 4 Years - 9 YearsAllIRCCS Eugenio Medea
NCT06937255 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The project represents the completion of a part of the recently concluded European project MultiMind, in which a computer platform called MuLiMi was developed and validated. The platform hosts screening tests for the identification of the risk of Language and Learning Disorders in preschool and primary school children, respectively. The aim is to validate the Dynamic Assessment (DA) tests (a first test assessing the capacity to learn new words for preschool children and a second one assessing the capacity to learn a new spelling code for school-age children) in a population of monolingual and bilingual children attending preschool and primary school. The main goal of the study is to complete the validation of the two Dynamic Assessment tests implemented in the MuLiMi platform developed for the MultiMind project.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * age 4-6 years (Kindergarten) or 7-9 years (Primary school); * Attendance at an Italian-language school in Italy or Switzerland/Germany. Additional inclusion criteria for the multilingual group only: * (i) At least one parent speaks at least one language other than Italian in the family; * (ii) Continuous exposure to the Italian language for at least two years. Exclusion Criteria: * Intellectual disability, major psychopathological disorders, exposure to Italian language for less than two years.
💊

What it tests

  • computerized Dynamic Assessment
📍

Where

1 site
IRCCS E. Medea, polo di Bosisio Parini
Bosisio Parini, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy